Crossref

1. Mixed probiotics reduce the severity of stress-induced depressive-like behaviors

- Xianguo Li

- Xukai Cheng

- Yongping Shi

- Chenxing Jian

- Wenzhong Zhu

- Haijun Bao

- Mi Jiang

- Zuojie Peng

- Yuan Hu

- Jinhuang Chen

- Xiaogang Shu

2. Mirogabalin prevents repeated restraint stress-induced dysfunction in mice

- Takashi Iwai

- Akinori Kikuchi

- Misa Oyama

- Shun Watanabe

- Mitsuo Tanabe

3. An overview of 5-HT3 receptor antagonists as a treatment option for irritable bowel syndrome with diarrhea

- Karolina Merecz

- Mikołaj Hirsa

- Olga Biniszewska

- Jakub Fichna

- Aleksandra Tarasiuk

5. Shaoyao‐Gancao Decoction Relieves Visceral Hyperalgesia in TNBS‐Induced Postinflammatory Irritable Bowel Syndrome via Inactivating Transient Receptor Potential Vanilloid Type 1 and Reducing Serotonin Synthesis

- Yun-Yun Shao

- Yi-Ting Guo

- Jian-ping Gao

- Jun-Jin Liu

- Zhuang-Peng Chang

- Xiao-Juan Feng

- Ding Xu

- Gui-Feng Deng

- Rui-Gang Hou

- XiuMin Li

6. Depression and Pain: Use of Antidepressants

- Herlinda Bonilla-Jaime

- José Armando Sánchez-Salcedo

- M. Maetzi Estevez-Cabrera

- Tania Molina-Jiménez

- José Luis Cortes-Altamirano

- Alfonso Alfaro-Rodríguez

7. Pharmacological approaches to treat intestinal pain

- Mikolaj Swierczynski

- Adam Makaro

- Agata Grochowska

- Maciej Salaga

8. Long‐lasting visceral hypersensitivity in a model of DSS‐induced colitis in rats

- Sergio López‐Estévez

- Josep Manuel López‐Torrellardona

- Marc Parera

- Vicente Martínez

9. Essential role of Cav3.2 T-type calcium channels in butyrate-induced colonic pain and nociceptor hypersensitivity in mice

- Maho Tsubota

- Kazuki Matsui

- Maki Nakano

- Rie Kajitani

- Yuko Ishii

- Ken Tomochika

- Yuta Nishikawa

- Saaya Fukushi

- Ayumu Yamagata

- Fumiko Sekiguchi

- Takuya Okada

- Naoki Toyooka

- Atsufumi Kawabata

10. Therapeutic effects of saffron (Crocus sativus) versus fluoxetine on Irritable Bowel Syndrome: A double-blind randomized clinical trial

- Borna Tadyon Najafabadi

- Kiandokht Ghamari

- Tahereh Kermany Ranjabari

- Ahmad Ali Noorbala

- Naser Ebrahimi Daryani

- Elmira Vanaki

- Shahin Akhondzadeh

11. Evaluation and Management Strategies for GI Involvement with Amyloidosis

- Cassandra D.L. Fritz

- Elizabeth Blaney

12. Monocyte/High-Density Lipoprotein Ratio as an Inflammatory Marker in Patients with Irritable Bowel Syndrome

- Çağdaş Erdoğan

- İbrahim Ethem Güven

- Batuhan Başpınar

- Zeki Mesut Yalın Kılıç

13.

14. Blocking peripheral drive from colorectal afferents by subkilohertz dorsal root ganglion stimulation

- Longtu Chen

- Tiantian Guo

- Shaopeng Zhang

- Phillip P. Smith

- Bin Feng

15. Improving the Treatment Response of Patients with Irritable Bowel Syndrome: Implementing a Second-Generation Artificial Intelligence System for Overcoming Resistance

- Anat Hershko-Moshe

- Yaako’v Hasin

- Anat Nevo-Shor

- Ohad Etzion

- Yaron Ilan

- Soe Thiha Maung

16. Potential neuro-immune therapeutic targets in irritable bowel syndrome

- Maite Casado-Bedmar

- Åsa V. Keita

17. Effect of Samryungbaekchul-san Combined with Otilonium Bromide on Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Randomized Controlled Trial

- Jin-Hyun Lee

- Joong Il Kim

- Myong Ki Baeg

- Yun-Young Sunwoo

- Kwangsun Do

- Jung-Han Lee

- Hye-Jung Kim

- Ja Sung Choi

- Jayoung Kim

- Chang-Seob Seo

- Hyeun-Kyoo Shin

- Hyekyung Ha

- Tae-Yong Park

18. Evidence-based clinical practice guidelines for irritable bowel syndrome 2020

- Shin Fukudo

- Toshikatsu Okumura

- Masahiko Inamori

- Yusuke Okuyama

- Motoyori Kanazawa

- Takeshi Kamiya

- Ken Sato

- Akiko Shiotani

- Yuji Naito

- Yoshiko Fujikawa

- Ryota Hokari

- Tastuhiro Masaoka

- Kazuma Fujimoto

- Hiroshi Kaneko

- Akira Torii

- Kei Matsueda

- Hiroto Miwa

- Nobuyuki Enomoto

- Tooru Shimosegawa

- Kazuhiko Koike

19. Comparisons of different electrical stimulation modalities for treating visceral pain in a rodent model of irritable bowel syndrome

- Md Jahangir Alam

- Tingting Zhao

- John W. Wiley

- Jiande D. Z. Chen

20. Endocannabinoid system modulation for visceral abdominal pain in inflammatory bowel disease and irritable bowel syndrome: A protocol for systematic review and meta-analysis

- Rebecca M. Lane

- Laurence J. Egan

- Brian E. McGuire

- Declan P. McKernan

- Siobhain M. O'Mahony

- David P. Finn

21. Effects of Electroacupuncture at ST36 on Visceral Pain and Inflammatory Markers in IBS Rats

- Ya‐bo Hao

- Yan‐lin Liu

- Xiao‐mei Wang

- Kai Cheng

- Qing‐yu Tu

- Fei Dai

- Xi‐bing Yang

22. Somatosensory Profiles Differentiate Pain and Psychophysiological Symptoms Among Young Adults With Irritable Bowel Syndrome

- Jie Chen

- Yiming Zhang

- Zahra A. Barandouzi

- Wanli Xu

- Bin Feng

- Ki Chon

- Melissa Santos

- Angela Starkweather

- Xiaomei Cong

23. Endocannabinoid system modulation for visceral abdominal pain in inflammatory bowel disease and irritable bowel syndrome: A protocol for systematic review and meta-analysis

- Rebecca M. Lane

- Laurence J. Egan

- Brian E. McGuire

- Declan P. McKernan

- Siobhain M. O'Mahony

- David P. Finn

24. Rifaximin and alternative agents in the management of irritable bowel syndrome: A comprehensive review

- Aylin Deljavan Ghodrati

- Tansel Comoglu

25. Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review

- Amber N. Edinoff

- Haseeb A. Akuly

- Tony A. Hanna

- Carolina O. Ochoa

- Shelby J. Patti

- Yahya A. Ghaffar

- Alan D. Kaye

- Omar Viswanath

- Ivan Urits

- Andrea G. Boyer

- Elyse M. Cornett

- Adam M. Kaye

26. Risk of psychiatric disorders in irritable bowel syndrome-A nationwide, population-based, cohort study

- Hui-Wen Yeh

- Wu-Chien Chien

- Chi-Hsiang Chung

- Je-Ming Hu

- Nian-Sheng Tzeng

27. Editorial: Emerging trends in abdominal and pelvic pain

- Bin Feng

- Anna P. Malykhina

28. The Associations of Single Nucleotide Polymorphisms with Risk and Symptoms of Irritable Bowel Syndrome

- Tingting Zhao

- Yiming Zhang

- Joochul Lee

- Angela R. Starkweather

- Erin E. Young

- Xiaomei Cong

29.

30. Pain Severity Correlates With Biopsy-Mediated Colonic Afferent Activation But Not Psychological Scores in Patients With IBS-D

- Vincent Cibert-Goton

- Ching Lam

- Melanie Lingaya

- Yirga Falcone

- John N. Wood

- David C. Bulmer

- Robin Spiller

31. Painful neurotrophins and their role in visceral pain

- Ana E. López-Pérez

- Kulmira Nurgali

- Raquel Abalo

32. Optical recording reveals topological distribution of functionally classified colorectal afferent neurons in intact lumbosacral DRG

- Tiantian Guo

- Zichao Bian

- Kyle Trocki

- Longtu Chen

- Guoan Zheng

- Bin Feng

33. Fecal microbiota transplantation ameliorates gut microbiota imbalance and intestinal barrier damage in rats with stress‐induced depressive‐like behavior

- Jingjing Rao

- Ruining Xie

- Li Lin

- Jian Jiang

- Lei Du

- Xindie Zeng

- Gongying Li

- Chunmei Wang

- Yi Qiao

- Camilla Bellone

34. Systematic Review on Herbal Preparations for Controlling Visceral Hypersensitivity in Functional Gastrointestinal Disorders

- Naser-Aldin Lashgari

- Nazanin Momeni Roudsari

- Saeideh Momtaz

- Faezeh Niazi Shahraki

- Nadia Zandi

- Benyamin Pazoki

- Mohammad Hosein Farzaei

- Mehdi Ghasemi

- Mohammad Abdollahi

- Amir Hossein Abdolghaffari

35. Oxytocin Verbindungen zur oralen Behandlung von Bauchschmerzen

- Thomas Kremsmayr

- Gudrun Schober

- Matthias Kaltenböck

- Bradley L. Hoare

- Stuart M. Brierley

- Markus Muttenthaler

36. Using the Rome IV Criteria to Help Manage the Complex IBS Patient

- Lisa D Lin

- Lin Chang

37. High-Throughput Functional Characterization of Visceral Afferents by Optical Recordings From Thoracolumbar and Lumbosacral Dorsal Root Ganglia

- Zichao Bian

- Tiantian Guo

- Shaowei Jiang

- Longtu Chen

- Jia Liu

- Guoan Zheng

- Bin Feng

38. Limited Utility for Benzodiazepines in Chronic Pain Management: A Narrative Review

- Steven L. Wright

39. Belgian consensus on irritable bowel syndrome

- S Kindt

- H Louis

- H De Schepper

- J Arts

- P Caenepeel

- D De Looze

- A Gerkens

- T Holvoet

- P Latour

- T Mahler

- F Mokaddem

- S Nullens

- H Piessevaux

- P Poortmans

- G Rasschaert

- M Surmont

- H Vafa

- K Van Malderen

- T Vanuytsel

- F Wuestenberghs

- J Tack

40. Why Use Nutraceutical Strategies for the Irritable Bowel Syndrome?

- Flavia di Michele

41. Antispasmodic Effect of Bergamot Essential Oil on Rat Isolated Gut Tissues

- Laura Rombolà

- Marilisa Straface

- Damiana Scuteri

- Tsukasa Sakurada

- Shinobu Sakurada

- Maria Tiziana Corasaniti

- Giacinto Bagetta

- Luigi Antonio Morrone

42. Complex visceral hyperalgesia in an adolescent with Pitt-Hopkins syndrome

- Laura Reaney

- Aedin Collins

43. Use of antidepressants and risks of restless legs syndrome in patients with irritable bowel syndrome: A population-based cohort study

- Yung-Chu Hsu

- Hsin-Yi Yang

- Wan-Ting Huang

- Solomon Chih-Cheng Chen

- Herng-Sheng Lee

- Rachel A. Annunziato

44. Pain management in a patient with intestinal failure in the palliative care setting: case report

- Adarsh Das

- Jayamangala Sampath Kondasinghe

45. Efficacy and safety of olorinab, a full agonist of the cannabinoid receptor 2, for the treatment of abdominal pain in patients with irritable bowel syndrome: Results from a phase 2b randomized placebo‐controlled trial (CAPTIVATE)

- Lin Chang

- Brooks D. Cash

- Anthony Lembo

- David C. Kunkel

- Brett A. English

- Beatriz Lindstrom

- Guibao Gu

- Sharon Skare

- Kye Gilder

- Stewart Turner

- Fabio Cataldi

- Donald Lipkis

- Jan Tack

46. Oxytocin Analogues for the Oral Treatment of Abdominal Pain

- Thomas Kremsmayr

- Gudrun Schober

- Matthias Kaltenböck

- Bradley L. Hoare

- Stuart M. Brierley

- Markus Muttenthaler

47. Improvement in constipation and diarrhea is associated with improved abdominal pain in patients with functional bowel disorders

- Vikram Rangan

- Prashant Singh

- Sarah Ballou

- Rafla Hassan

- Vanessa Yu

- Jesse Katon

- Judy Nee

- Johanna Iturrino

- Anthony Lembo

48. New Insights on Expression and Function of Mu and Delta Opioid Receptors in Mouse Gastrointestinal Tract

- Bin Feng

49. Blocking Aδ- and C-fiber neural transmission by sub-kilohertz peripheral nerve stimulation

- Shaopeng Zhang

- Longtu Chen

- Sajjad Rigi Ladez

- Ahmet Seferge

- Jia Liu

- Bin Feng

50. Evaluation of the mechanism of action of paracetamol, drotaverine, and peppermint oil and their effects in combination with hyoscine butylbromide on colonic motility: human ex-vivo study

- Sara Traserra

- Claudia Barber

- Luis Gerardo Alcalá-González

- Stefania Landolfi

- Robert Lange

- Carolina Malagelada

- Maura Corsetti

- Marcel Jimenez

51. In Silico Food-Drug Interaction: A Case Study of Eluxadoline and Fatty Meal

- Annalisa Maruca

- Antonio Lupia

- Roberta Rocca

- Daniel Keszthelyi

- Maura Corsetti

- Stefano Alcaro

52. Review article: current and future treatment approaches for pain in IBS

- Peter Paine

53. The effect of eye movement desensitization and reprocessing (EMDR) on abdominal pain in patients with irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial (EMDR4IBS)

- B. Wertheim

- E. E. Aarts

- C. de Roos

- Y. R. van Rood

54. Optimizing Pain Management in Palliative Care for a Patient with Intestinal Failure: A Case Report

- Hanadi Suhail

- Edina Bihari

- Edina Lempel

55. 5-HT3 receptor signaling in serotonin transporter-knockout rats: a female sex-specific animal model of visceral hypersensitivity

- Nadine El-Ayache

- James J. Galligan

56. Alterations of colonic sensitivity and gastric dysmotility after acute cisplatin and granisetron

- Marta Martín‐Ruíz

- José A. Uranga

- Paula Mosinska

- Jakub Fichna

- Kulmira Nurgali

- Mª Isabel Martín‐Fontelles

- Raquel Abalo

57. A Multimodal Intervention Using Nonopioid Analgesics Is Associated With Reduced Intravenous Opioid Exposure Among Hospitalized Patients With Inflammatory Bowel Diseases

- Rahul S. Dalal

- Sonali Palchaudhuri

- Christopher K. Snider

- Yevgeniy Gitelman

- Mihir Brahmbhatt

- Nikhil K. Mull

- Shivan J. Mehta

- Christopher Klock

- James D. Lewis

- Gary R. Lichtenstein

58. Chlorogenic acid improves intestinal barrier function by downregulating CD14 to inhibit the NF-κB signaling pathway

- Lei-Min Yu

- Li-Qi Mao

- Chun-Yan Wu

- Wei Ye

- Xi Wang

59. How Serotonin Level Fluctuation Affects the Effectiveness of Treatment in Irritable Bowel Syndrome

- Ilmaben S Vahora

- Nicholas Tsouklidis

- Rajat Kumar

- Ravi Soni

- Safeera Khan

60. NUCB2/Nesfatin-1 Regulation of Chronic Visceral Hyperalgesia

- Qiaoyan Gu

- Yuan Lei

- Jianming Wu

- Ting He

- Juanjuan Li

- Shanshan Song

- Fahd Abd Algalil

61. Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study

- Rodrigo Vázquez-Frias

- Alejandra Consuelo-Sánchez

- Carlos Patricio Acosta-Rodríguez-Bueno

- Andrés Blanco-Montero

- Daniel Casas Robles

- Vanessa Cohen

- Daniel Márquez

- Marcos Perez

62. Effects of Duloxetine on Gastrointestinal Symptoms, Depression, Anxiety, Stress, and Quality of Life in Patients with the Moderate-to-Severe Irritable Bowel Syndrome

- Mohammad Reza Sharbafchi

- Hamid Afshar Zanjani

- Zahra Saneian

- Awat Feizi

- Hamed Daghaghzadeh

- Peyman Adibi

63. Trimebutine: a state-of-the-art review

- Beatrice Salvioli

64. Can Sertraline and Nortriptyline Protect the Neurons in Submucosal and Myenteric Plexuses of Rat’s Colon Against Stress?

- Ali Noorafshan

- Majid Yousefi

- Leila Hosseini

- Saied Karbalay-Doust